AFF2 and fragile X syndrome: In order to update our diagnostic approach to FXS, we set up an internal procedure to validate the commercial kit MS-MLPA SALSA ME029-B1 FMR1/AFF2, designed to investigate both the methylation status of the FMR1 gene promoter and the gene copy number of the FRAXA locus.